The global market for Implantable Neuromodulation System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

An implantable neuromodulation system is a medical device that is surgically implanted within the body to modulate or alter nervous system activity. These devices are used for treating various neurological and neuropsychiatric conditions by delivering electrical or chemical stimuli to specific nerves or areas of the brain.

North American market for Implantable Neuromodulation System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Implantable Neuromodulation System is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Implantable Neuromodulation System include Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Implantable Neuromodulation System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Implantable Neuromodulation System.

The Implantable Neuromodulation System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Implantable Neuromodulation System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Implantable Neuromodulation System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Implantable Neuromodulation System Market Report

Report Metric	Details
Report Name	Implantable Neuromodulation System Market
Segment by Type	Spinal Cord Stimulation Deep Brain Stimulation Sacral Nerve Stimulation Vagal Nerve Stimulation Gastric Stimulation Other
Segment by Application	Parkinson's Disease Epilepsy Pain Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Implantable Neuromodulation System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Implantable Neuromodulation System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Implantable Neuromodulation System Market report?

Ans: The main players in the Implantable Neuromodulation System Market are Medtronic, Abbott, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical

What are the Application segmentation covered in the Implantable Neuromodulation System Market report?

Ans: The Applications covered in the Implantable Neuromodulation System Market report are Parkinson's Disease, Epilepsy, Pain, Other

What are the Type segmentation covered in the Implantable Neuromodulation System Market report?

Ans: The Types covered in the Implantable Neuromodulation System Market report are Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Other

1 Implantable Neuromodulation System Market Overview

1.1 Product Definition

1.2 Implantable Neuromodulation System by Type

1.2.1 Global Implantable Neuromodulation System Market Value Comparison by Type (2024 VS 2031)

1.2.2 Spinal Cord Stimulation

1.2.3 Deep Brain Stimulation

1.2.4 Sacral Nerve Stimulation

1.2.5 Vagal Nerve Stimulation

1.2.6 Gastric Stimulation

1.2.7 Other

1.3 Implantable Neuromodulation System by Application

1.3.1 Global Implantable Neuromodulation System Market Value by Application (2024 VS 2031)

1.3.2 Parkinson's Disease

1.3.3 Epilepsy

1.3.4 Pain

1.3.5 Other

1.4 Global Implantable Neuromodulation System Market Size Estimates and Forecasts

1.4.1 Global Implantable Neuromodulation System Revenue 2020-2031

1.4.2 Global Implantable Neuromodulation System Sales 2020-2031

1.4.3 Global Implantable Neuromodulation System Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Implantable Neuromodulation System Market Competition by Manufacturers

2.1 Global Implantable Neuromodulation System Sales Market Share by Manufacturers (2020-2025)

2.2 Global Implantable Neuromodulation System Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Implantable Neuromodulation System Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Implantable Neuromodulation System, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Implantable Neuromodulation System, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Implantable Neuromodulation System, Product Type & Application

2.7 Global Key Manufacturers of Implantable Neuromodulation System, Date of Enter into This Industry

2.8 Global Implantable Neuromodulation System Market Competitive Situation and Trends

2.8.1 Global Implantable Neuromodulation System Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Implantable Neuromodulation System Players Market Share by Revenue

2.8.3 Global Implantable Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Implantable Neuromodulation System Market Scenario by Region

3.1 Global Implantable Neuromodulation System Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Implantable Neuromodulation System Sales by Region: 2020-2031

3.2.1 Global Implantable Neuromodulation System Sales by Region: 2020-2025

3.2.2 Global Implantable Neuromodulation System Sales by Region: 2026-2031

3.3 Global Implantable Neuromodulation System Revenue by Region: 2020-2031

3.3.1 Global Implantable Neuromodulation System Revenue by Region: 2020-2025

3.3.2 Global Implantable Neuromodulation System Revenue by Region: 2026-2031

3.4 North America Implantable Neuromodulation System Market Facts & Figures by Country

3.4.1 North America Implantable Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Implantable Neuromodulation System Sales by Country (2020-2031)

3.4.3 North America Implantable Neuromodulation System Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Implantable Neuromodulation System Market Facts & Figures by Country

3.5.1 Europe Implantable Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Implantable Neuromodulation System Sales by Country (2020-2031)

3.5.3 Europe Implantable Neuromodulation System Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Implantable Neuromodulation System Market Facts & Figures by Region

3.6.1 Asia Pacific Implantable Neuromodulation System Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Implantable Neuromodulation System Sales by Region (2020-2031)

3.6.3 Asia Pacific Implantable Neuromodulation System Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Implantable Neuromodulation System Market Facts & Figures by Country

3.7.1 Latin America Implantable Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Implantable Neuromodulation System Sales by Country (2020-2031)

3.7.3 Latin America Implantable Neuromodulation System Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Implantable Neuromodulation System Market Facts & Figures by Country

3.8.1 Middle East and Africa Implantable Neuromodulation System Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Implantable Neuromodulation System Sales by Country (2020-2031)

3.8.3 Middle East and Africa Implantable Neuromodulation System Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Implantable Neuromodulation System Sales by Type (2020-2031)

4.1.1 Global Implantable Neuromodulation System Sales by Type (2020-2025)

4.1.2 Global Implantable Neuromodulation System Sales by Type (2026-2031)

4.1.3 Global Implantable Neuromodulation System Sales Market Share by Type (2020-2031)

4.2 Global Implantable Neuromodulation System Revenue by Type (2020-2031)

4.2.1 Global Implantable Neuromodulation System Revenue by Type (2020-2025)

4.2.2 Global Implantable Neuromodulation System Revenue by Type (2026-2031)

4.2.3 Global Implantable Neuromodulation System Revenue Market Share by Type (2020-2031)

4.3 Global Implantable Neuromodulation System Price by Type (2020-2031)

5 Segment by Application

5.1 Global Implantable Neuromodulation System Sales by Application (2020-2031)

5.1.1 Global Implantable Neuromodulation System Sales by Application (2020-2025)

5.1.2 Global Implantable Neuromodulation System Sales by Application (2026-2031)

5.1.3 Global Implantable Neuromodulation System Sales Market Share by Application (2020-2031)

5.2 Global Implantable Neuromodulation System Revenue by Application (2020-2031)

5.2.1 Global Implantable Neuromodulation System Revenue by Application (2020-2025)

5.2.2 Global Implantable Neuromodulation System Revenue by Application (2026-2031)

5.2.3 Global Implantable Neuromodulation System Revenue Market Share by Application (2020-2031)

5.3 Global Implantable Neuromodulation System Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Company Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Medtronic Implantable Neuromodulation System Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Abbott

6.2.1 Abbott Company Information

6.2.2 Abbott Description and Business Overview

6.2.3 Abbott Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Abbott Implantable Neuromodulation System Product Portfolio

6.2.5 Abbott Recent Developments/Updates

6.3 Boston Scientific Corporation

6.3.1 Boston Scientific Corporation Company Information

6.3.2 Boston Scientific Corporation Description and Business Overview

6.3.3 Boston Scientific Corporation Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Boston Scientific Corporation Implantable Neuromodulation System Product Portfolio

6.3.5 Boston Scientific Corporation Recent Developments/Updates

6.4 St. Jude Medical

6.4.1 St. Jude Medical Company Information

6.4.2 St. Jude Medical Description and Business Overview

6.4.3 St. Jude Medical Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.4.4 St. Jude Medical Implantable Neuromodulation System Product Portfolio

6.4.5 St. Jude Medical Recent Developments/Updates

6.5 Synapse Biomedical

6.5.1 Synapse Biomedical Company Information

6.5.2 Synapse Biomedical Description and Business Overview

6.5.3 Synapse Biomedical Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Synapse Biomedical Implantable Neuromodulation System Product Portfolio

6.5.5 Synapse Biomedical Recent Developments/Updates

6.6 Nevro Corporation

6.6.1 Nevro Corporation Company Information

6.6.2 Nevro Corporation Description and Business Overview

6.6.3 Nevro Corporation Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Nevro Corporation Implantable Neuromodulation System Product Portfolio

6.6.5 Nevro Corporation Recent Developments/Updates

6.7 Neuropace

6.7.1 Neuropace Company Information

6.7.2 Neuropace Description and Business Overview

6.7.3 Neuropace Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Neuropace Implantable Neuromodulation System Product Portfolio

6.7.5 Neuropace Recent Developments/Updates

6.8 Cyberonics

6.8.1 Cyberonics Company Information

6.8.2 Cyberonics Description and Business Overview

6.8.3 Cyberonics Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Cyberonics Implantable Neuromodulation System Product Portfolio

6.8.5 Cyberonics Recent Developments/Updates

6.9 Autonomic Technologies

6.9.1 Autonomic Technologies Company Information

6.9.2 Autonomic Technologies Description and Business Overview

6.9.3 Autonomic Technologies Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Autonomic Technologies Implantable Neuromodulation System Product Portfolio

6.9.5 Autonomic Technologies Recent Developments/Updates

6.10 Avery Biomedical

6.10.1 Avery Biomedical Company Information

6.10.2 Avery Biomedical Description and Business Overview

6.10.3 Avery Biomedical Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Avery Biomedical Implantable Neuromodulation System Product Portfolio

6.10.5 Avery Biomedical Recent Developments/Updates

6.11 Greatbatch Medical

6.11.1 Greatbatch Medical Company Information

6.11.2 Greatbatch Medical Description and Business Overview

6.11.3 Greatbatch Medical Implantable Neuromodulation System Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Greatbatch Medical Implantable Neuromodulation System Product Portfolio

6.11.5 Greatbatch Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Implantable Neuromodulation System Industry Chain Analysis

7.2 Implantable Neuromodulation System Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Implantable Neuromodulation System Production Mode & Process Analysis

7.4 Implantable Neuromodulation System Sales and Marketing

7.4.1 Implantable Neuromodulation System Sales Channels

7.4.2 Implantable Neuromodulation System Distributors

7.5 Implantable Neuromodulation System Customer Analysis

8 Implantable Neuromodulation System Market Dynamics

8.1 Implantable Neuromodulation System Industry Trends

8.2 Implantable Neuromodulation System Market Drivers

8.3 Implantable Neuromodulation System Market Challenges

8.4 Implantable Neuromodulation System Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Abbott

Boston Scientific Corporation

Autonomic Technologies

Avery Biomedical

Greatbatch Medical

List of Tables

Table 1. Global Implantable Neuromodulation System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Implantable Neuromodulation System Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Implantable Neuromodulation System Market Competitive Situation by Manufacturers in 2024

Table 4. Global Implantable Neuromodulation System Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Implantable Neuromodulation System Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Implantable Neuromodulation System Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Implantable Neuromodulation System Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Implantable Neuromodulation System Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Implantable Neuromodulation System, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Implantable Neuromodulation System, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Implantable Neuromodulation System, Product Type & Application

Table 12. Global Key Manufacturers of Implantable Neuromodulation System, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Implantable Neuromodulation System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Implantable Neuromodulation System as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Implantable Neuromodulation System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Implantable Neuromodulation System Sales by Region (2020-2025) & (K Units)

Table 18. Global Implantable Neuromodulation System Sales Market Share by Region (2020-2025)

Table 19. Global Implantable Neuromodulation System Sales by Region (2026-2031) & (K Units)

Table 20. Global Implantable Neuromodulation System Sales Market Share by Region (2026-2031)

Table 21. Global Implantable Neuromodulation System Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Implantable Neuromodulation System Revenue Market Share by Region (2020-2025)

Table 23. Global Implantable Neuromodulation System Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Implantable Neuromodulation System Revenue Market Share by Region (2026-2031)

Table 25. North America Implantable Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Implantable Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 27. North America Implantable Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 28. North America Implantable Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Implantable Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Implantable Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Implantable Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 32. Europe Implantable Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 33. Europe Implantable Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Implantable Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Implantable Neuromodulation System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Implantable Neuromodulation System Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Implantable Neuromodulation System Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Implantable Neuromodulation System Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Implantable Neuromodulation System Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Implantable Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Implantable Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Implantable Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Implantable Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Implantable Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Implantable Neuromodulation System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Implantable Neuromodulation System Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Implantable Neuromodulation System Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Implantable Neuromodulation System Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Implantable Neuromodulation System Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Implantable Neuromodulation System Sales (K Units) by Type (2020-2025)

Table 51. Global Implantable Neuromodulation System Sales (K Units) by Type (2026-2031)

Table 52. Global Implantable Neuromodulation System Sales Market Share by Type (2020-2025)

Table 53. Global Implantable Neuromodulation System Sales Market Share by Type (2026-2031)

Table 54. Global Implantable Neuromodulation System Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Implantable Neuromodulation System Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Implantable Neuromodulation System Revenue Market Share by Type (2020-2025)

Table 57. Global Implantable Neuromodulation System Revenue Market Share by Type (2026-2031)

Table 58. Global Implantable Neuromodulation System Price (US$/Unit) by Type (2020-2025)

Table 59. Global Implantable Neuromodulation System Price (US$/Unit) by Type (2026-2031)

Table 60. Global Implantable Neuromodulation System Sales (K Units) by Application (2020-2025)

Table 61. Global Implantable Neuromodulation System Sales (K Units) by Application (2026-2031)

Table 62. Global Implantable Neuromodulation System Sales Market Share by Application (2020-2025)

Table 63. Global Implantable Neuromodulation System Sales Market Share by Application (2026-2031)

Table 64. Global Implantable Neuromodulation System Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Implantable Neuromodulation System Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Implantable Neuromodulation System Revenue Market Share by Application (2020-2025)

Table 67. Global Implantable Neuromodulation System Revenue Market Share by Application (2026-2031)

Table 68. Global Implantable Neuromodulation System Price (US$/Unit) by Application (2020-2025)

Table 69. Global Implantable Neuromodulation System Price (US$/Unit) by Application (2026-2031)

Table 70. Medtronic Company Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Medtronic Implantable Neuromodulation System Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Abbott Company Information

Table 76. Abbott Description and Business Overview

Table 77. Abbott Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Abbott Implantable Neuromodulation System Product

Table 79. Abbott Recent Developments/Updates

Table 80. Boston Scientific Corporation Company Information

Table 81. Boston Scientific Corporation Description and Business Overview

Table 82. Boston Scientific Corporation Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Boston Scientific Corporation Implantable Neuromodulation System Product

Table 84. Boston Scientific Corporation Recent Developments/Updates

Table 85. St. Jude Medical Company Information

Table 86. St. Jude Medical Description and Business Overview

Table 87. St. Jude Medical Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. St. Jude Medical Implantable Neuromodulation System Product

Table 89. St. Jude Medical Recent Developments/Updates

Table 90. Synapse Biomedical Company Information

Table 91. Synapse Biomedical Description and Business Overview

Table 92. Synapse Biomedical Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Synapse Biomedical Implantable Neuromodulation System Product

Table 94. Synapse Biomedical Recent Developments/Updates

Table 95. Nevro Corporation Company Information

Table 96. Nevro Corporation Description and Business Overview

Table 97. Nevro Corporation Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Nevro Corporation Implantable Neuromodulation System Product

Table 99. Nevro Corporation Recent Developments/Updates

Table 100. Neuropace Company Information

Table 101. Neuropace Description and Business Overview

Table 102. Neuropace Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Neuropace Implantable Neuromodulation System Product

Table 104. Neuropace Recent Developments/Updates

Table 105. Cyberonics Company Information

Table 106. Cyberonics Description and Business Overview

Table 107. Cyberonics Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Cyberonics Implantable Neuromodulation System Product

Table 109. Cyberonics Recent Developments/Updates

Table 110. Autonomic Technologies Company Information

Table 111. Autonomic Technologies Description and Business Overview

Table 112. Autonomic Technologies Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Autonomic Technologies Implantable Neuromodulation System Product

Table 114. Autonomic Technologies Recent Developments/Updates

Table 115. Avery Biomedical Company Information

Table 116. Avery Biomedical Description and Business Overview

Table 117. Avery Biomedical Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Avery Biomedical Implantable Neuromodulation System Product

Table 119. Avery Biomedical Recent Developments/Updates

Table 120. Greatbatch Medical Company Information

Table 121. Greatbatch Medical Description and Business Overview

Table 122. Greatbatch Medical Implantable Neuromodulation System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Greatbatch Medical Implantable Neuromodulation System Product

Table 124. Greatbatch Medical Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Implantable Neuromodulation System Distributors List

Table 128. Implantable Neuromodulation System Customers List

Table 129. Implantable Neuromodulation System Market Trends

Table 130. Implantable Neuromodulation System Market Drivers

Table 131. Implantable Neuromodulation System Market Challenges

Table 132. Implantable Neuromodulation System Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Implantable Neuromodulation System

Figure 2. Global Implantable Neuromodulation System Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Implantable Neuromodulation System Market Share by Type: 2024 & 2031

Figure 4. Spinal Cord Stimulation Product Picture

Figure 5. Deep Brain Stimulation Product Picture

Figure 6. Sacral Nerve Stimulation Product Picture

Figure 7. Vagal Nerve Stimulation Product Picture

Figure 8. Gastric Stimulation Product Picture

Figure 9. Other Product Picture

Figure 10. Global Implantable Neuromodulation System Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Implantable Neuromodulation System Market Share by Application: 2024 & 2031

Figure 12. Parkinson's Disease

Figure 13. Epilepsy

Figure 14. Pain

Figure 15. Other

Figure 16. Global Implantable Neuromodulation System Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Implantable Neuromodulation System Market Size (2020-2031) & (US$ Million)

Figure 18. Global Implantable Neuromodulation System Sales (2020-2031) & (K Units)

Figure 19. Global Implantable Neuromodulation System Average Price (US$/Unit) & (2020-2031)

Figure 20. Implantable Neuromodulation System Report Years Considered

Figure 21. Implantable Neuromodulation System Sales Share by Manufacturers in 2024

Figure 22. Global Implantable Neuromodulation System Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Implantable Neuromodulation System Players: Market Share by Revenue in Implantable Neuromodulation System in 2024

Figure 24. Implantable Neuromodulation System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Implantable Neuromodulation System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Implantable Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 27. North America Implantable Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 28. United States Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Implantable Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 31. Europe Implantable Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 32. Germany Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Implantable Neuromodulation System Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Implantable Neuromodulation System Revenue Market Share by Region (2020-2031)

Figure 39. China Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. China Taiwan Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Implantable Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 47. Latin America Implantable Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Implantable Neuromodulation System Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Implantable Neuromodulation System Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Implantable Neuromodulation System Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Implantable Neuromodulation System by Type (2020-2031)

Figure 57. Global Revenue Market Share of Implantable Neuromodulation System by Type (2020-2031)

Figure 58. Global Implantable Neuromodulation System Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Implantable Neuromodulation System by Application (2020-2031)

Figure 60. Global Revenue Market Share of Implantable Neuromodulation System by Application (2020-2031)

Figure 61. Global Implantable Neuromodulation System Price (US$/Unit) by Application (2020-2031)

Figure 62. Implantable Neuromodulation System Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Implantable Neurostimulation System Market Research Report 2024

Global Non invasive Neuromodulation Device Market Research Report 2024

Global Implantable Neurostimulators Market Research Report 2024

Implantable Neurostimulation Devices Market

Global Home Neuromodulation Device Market Research Report 2024

Global Ocular Neuromodulation Device Market Research Report 2025

Global Neuromodulation and Neurostimulation Pain Management Devices Market Research Report 2024

Internal Neuromodulation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Sacral Neuromodulation System Market Insights Forecast to 2030

Global Neurostimulation and Neuromodulation Device Market Research Report 2024

Low Frequency Sine Wave Neurostimulation Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Internal Neurostimulation Devices Market Research Report 2024

Global Implantable Ocular Neurostimulator Market Research Report 2025

Global Obesity Treating Neuromodulation System Market Research Report 2024

Non Invasive Neuromodulatory Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Deep Brain Stimulation Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neuromodulation Devices and Implantable Infusion Pumps Market

Internal Neuromodulation Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Deep Brain Stimulation DBS Devices Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions